⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30254807 | 1.00 | — | — | |
| SCHEMBL29805509 | 0.71 | — | — | |
| SCHEMBL23235911 | 0.00 | — | — | |
| SCHEMBL25393921 | 0.00 | — | — | |
| SCHEMBL23644895 | 0.00 | — | — | |
| SCHEMBL23462224 | 0.00 | — | — | |
| Hydrogen Sulfide SCHEMBL23805181 | 0.00 | — | — | |
| SCHEMBL25436537 | 0.00 | — | — | |
| Potassium Ion SCHEMBL23461973 | 0.00 | CA4 (0.50) | — | |
| Potassium Ion SCHEMBL23462161 | 0.00 | CA4 (0.50) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 510 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260115336-A1 | MOFS WITH BETA-EMITTERS FOR RADIOTHERAPY | NODE PHARMA AS (NO) | 2026-04-30 | — | — | US | claimed |
| US-20260115332-A1 | Fibroblast Activation Protein Alpha-Cleavable Pro-Peptides and Methods of Use | UNIV CALIFORNIA (US) | 2026-04-30 | — | — | US | claimed |
| US-20260083866-A1 | COMPOSITIONS TARGETING ENDOTHELIAL CELLS AND USES THEREOF | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2026-03-26 | — | — | US | claimed |
| EP-4646234-A1 | MOFS WITH BETA-EMITTERS FOR RADIOTHERAPY | Node Pharma AS (NO) | 2025-11-12 | — | — | EP | claimed |
| US-20250332298-A1 | PEPTIDE-COUPLED ALGINATE GELS COMPRISING RADIONUCLIDES | BLUE WAVE THERAPEUTICS GMBH (CH) | 2025-10-30 | — | — | US | claimed |
| EP-4601726-A1 | DEVICE AND METHOD FOR GENERATING A RADIOLABELED DRY AEROSOL | Almedis Altmann GmbH (DE) | 2025-08-20 | — | — | EP | claimed |
| US-20250213737-A1 | MICROSPHERE AND PREPARATION METHOD THEREOF | PLATINUM OPTICS TECHNOLOGY INC. (TW) | 2025-07-03 | — | — | US | claimed |
| EP-4577554-A2 | FIBROBLAST ACTIVATION PROTEIN ALPHA-CLEAVABLE PRO-PEPTIDES AND METHODS OF USE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-07-02 | — | — | EP | claimed |
| EP-4578496-A1 | MICROSPHERE AND PREPARATION METHOD THEREOF | Platinum Optics Technology Inc. (TW) | 2025-07-02 | — | — | EP | claimed |
| US-20250122304-A1 | PRE-TARGETING | PRECIRIX N.V. (BE) | 2025-04-17 | — | — | US | claimed |
| WO-2023014988-A1 | CONJUGATES COMPRISING COVALENT BINDERS FOR TARGETING INTRACELLULAR PROTEINS | RAYZEBIO, INC. (US) | 2023-02-09 | — | — | WO | claimed |
| WO-2023014979-A1 | CONJUGATES COMPRISING COVALENT BINDERS FOR TARGETING INTRACELLULAR KRAS G12C PROTEINS | RAYZEBIO, INC. (US) | 2023-02-09 | — | — | WO | claimed |
| US-20230039076-A1 | ALBUMIN VARIANTS AND CONJUGATES | SARTORIUS ALBUMEDIX LIMITED (GB) | 2023-02-09 | — | — | US | claimed |
| WO-2023278737-A1 | GRANZYME-ACTIVATABLE MEMBRANE-INTERACTING PEPTIDES AND METHODS OF USE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-01-05 | — | — | WO | claimed |
| US-11541062-B2 | Methods of treating advanced prostate cancer | CITY OF HOPE (US) | 2023-01-03 | — | — | US | claimed |
| WO-2022185315-A1 | CONFORMATIONAL CONSTRAINED SOMATOSTATIN RECEPTOR 3 PEPTIDE LIGANDS AND THEIR CONJUGATES AND USES THEREOF | STARGET PHARMA LTD. (IL) | 2022-09-09 | — | — | WO | claimed |
| CN-114740519-A | Combined analysis method of strontium-89, strontium-90, iron-55, iron-59 and nickel-63 in water | 山东核电有限公司 | 2022-07-12 | — | — | CN | claimed |
| CN-110227170-B | Radioactive microsphere and preparation method thereof | 白金科技股份有限公司 | 2022-06-14 | — | — | CN | claimed |
| US-20220162284-A1 | SYNTHETIC SOMATOSTATIN RECEPTOR LIGANDS | TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. (IL) | 2022-05-26 | — | — | US | claimed |
| WO-2022053651-A2 | ANTIBODY FRAGMENT AGAINST FAP | PRECIRIX N.V. (BE) | 2022-03-17 | — | — | WO | claimed |